13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-13, with 85 holding rows worth $746,014,464.
- Accession
- 0001839882-25-008942
- Filer
- CIK 1773195
- Filed
- 2025-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 85 entries on the cover page, a total value of $746,014,464 stated on the cover page (in dollars after the unit check, H1), rows summing to $746,014,464 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 750,000 | $67,545,000 | dollars as filed | put |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,161,237 | $45,520,490 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 931,728 | $42,207,278 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 425,000 | $32,593,250 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 1,100,000 | $31,636,000 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,400,000 | $30,856,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 660,000 | $30,650,400 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 82,500 | $25,457,025 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 460,000 | $23,519,800 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 285,000 | $22,309,800 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 824,328 | $19,190,356 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,500,000 | $18,555,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,095,924 | $18,356,727 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 425,000 | $17,973,250 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 940,083 | $17,711,164 | dollars as filed | |
| MESOBLAST LTD | 590717401 | SPONS ADR | 838,600 | $16,604,280 | dollars as filed | put |
| MERUS N V | N5749R100 | COM | 389,241 | $16,367,584 | dollars as filed | |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 16,625,000 | $16,189,425 | dollars as filed | principal |
| OMEROS CORP | 682143AG7 | NOTE 5.250% 2/1 | 15,525,000 | $14,614,899 | dollars as filed | principal |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 279,445 | $12,874,031 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 630,000 | $12,077,100 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 15,250,000 | $11,867,515 | dollars as filed | principal |
| INOZYME PHARMA INC | 45790W108 | COM | 3,972,318 | $11,003,321 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 425,000 | $10,922,500 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 4,500,000 | $10,575,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,250,000 | $7,965,000 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 30,000 | $7,819,200 | dollars as filed | call |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,575,000 | $7,717,500 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 2,825,000 | $7,486,250 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 368,698 | $7,149,054 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 75,000 | $6,345,750 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,499,431 | $6,273,572 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 130,000 | $5,843,500 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 6,000,000 | $5,744,073 | dollars as filed | principal |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 300,000 | $5,640,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 200,000 | $5,488,000 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 475,000 | $5,035,000 | dollars as filed | call |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 130,000 | $5,018,000 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 350,000 | $4,308,500 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 1,300,000 | $4,147,000 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 1,739,400 | $4,104,984 | dollars as filed | put |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 550,765 | $4,092,184 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 350,000 | $3,563,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 200,000 | $3,484,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 50,000 | $3,452,000 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 237,935 | $3,331,090 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 850,512 | $3,214,935 | dollars as filed | |
| GALECTIN THERAPEUTICS INC | 363225202 | COMMON STOCK | 2,492,000 | $3,214,680 | dollars as filed | put |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 263,817 | $3,213,291 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 159,614 | $3,059,800 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 70,742 | $2,925,182 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 100,000 | $2,868,000 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 58,331 | $2,693,142 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 250,000 | $2,625,000 | dollars as filed | |
| OAKTREE ACQUISITION CORP III | G6717R120 | UNIT 10/04/2029 | 250,000 | $2,537,500 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 100,000 | $2,477,000 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 800,000 | $2,120,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 25,000 | $2,046,500 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 800,000 | $1,992,000 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 2,302,598 | $1,775,303 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 300,000 | $1,674,000 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 40,000 | $1,609,200 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 50,000 | $1,595,500 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,000,000 | $1,580,000 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 25,000 | $1,276,250 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 410,586 | $1,260,499 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 144,159 | $1,239,767 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 559,163 | $1,196,609 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,015,340 | $1,066,107 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 142,316 | $956,364 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 500,000 | $900,000 | dollars as filed | |
| RADIOPHARM THERANOSTICS LTD | 75041J101 | SPONSORED ADS | 156,171 | $684,029 | dollars as filed | |
| IMMUNITYBIO INC | 45256X103 | COM | 250,000 | $640,000 | dollars as filed | put |
| BIOMEA FUSION INC | 09077A106 | CMN | 150,000 | $582,000 | dollars as filed | put |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 223,335 | $558,338 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,541,200 | $354,168 | dollars as filed | put |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 9,992 | $252,498 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 213,235 | $223,897 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 100,000 | $131,000 | dollars as filed | |
| OMEROS CORP | 682143102 | COM | 9,958 | $98,385 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 27,777 | $95,553 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $47,082 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 150,000 | $34,470 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 200 | $8,990 | dollars as filed | call |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $2,573 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001839882-25-008942 | this filing | 2025-02-13 | acceptance time not in the bulk data set |